1,198
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma

, , , , , , , , , , ORCID Icon & show all
Article: 2227777 | Received 13 Jan 2023, Accepted 01 Jun 2023, Published online: 26 Jun 2023

References

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3
  • Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
  • Wang W-J, Wang Y, Chen H-Z, Xing Y-Z, Li F-W, Zhang Q, Zhou B, Zhang H-K, Zhang J, Bian X-L, et al. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat Chem Biol. 2014;10(2):133–140. doi:10.1038/nchembio.1406
  • Li X-X, Wang Z-J, Zheng Y, Guan Y-F, Yang P-B, Chen X, Peng C, He J-P, Ai Y-L, Wu S-F, et al. Nuclear receptor Nur77 facilitates melanoma cell survival under metabolic stress by protecting fatty acid oxidation. Mol Cell. 2018;69(3):480–492.e487. doi:10.1016/j.molcel.2018.01.001
  • Chen H-Z, Li L, Wang W-J, Du X-D, Wen Q, He J-P, Zhao B-X, Li G-D, Zhou W, Xia Y, et al. Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis. Oncogene. 2012;31(23):2876–2887. doi:10.1038/onc.2011.463
  • Lin H, Lin Q, Liu M, Lin Y, Wang X, Chen H, Xia Z, Lu B, Ding F, Wu Q, et al. PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis. Oncogene. 2014;33(13):1629–1639. doi:10.1038/onc.2013.116
  • Dodat F, Mader S, Lévesque D. Minireview: what is known about SUMOylation among NR4A Family Members? J Mol Biol. 2021;433(21):167212. doi:10.1016/j.jmb.2021.167212
  • Yang P-B, Hou P-P, Liu F-Y, Hong W-B, Chen H-Z, Sun X-Y, Li P, Zhang Y, Ju C-Y, Luo L-J, et al. Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Acad Sci USA. 2020;117(44):27412–27422. doi:10.1073/pnas.2002997117
  • Chen H-Z, Liu Q-F, Li L, Wang W-J, Yao L-M, Yang M, Liu B, Chen W, Zhan Y-Y, Zhang M-Q, et al. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Gut. 2012;61(5):714–724. doi:10.1136/gutjnl-2011-300783
  • Bian X-L, Chen H-Z, Yang P-B, Li Y-P, Zhang F-N, Zhang J-Y, Wang W-J, Zhao W-X, Zhang S, Chen Q-T, et al. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation. Nat Commun. 2017;8:14420. doi:10.1038/ncomms14420
  • Niu B, Liu J, Lv B, Lin J, Li X, Wu C, Jiang X, Zeng Z, Zhang X-K, Zhou H, et al. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis. Nat Commun. 2021;12(1):2809. doi:10.1038/s41467-021-23048-5
  • Karki K, Mohankumar K, Schoeller A, Martin G, Shrestha R, Safe S. NR4A1 ligands as potent inhibitors of breast cancer cell and tumor growth. Cancers . 2021;13(11):2682. doi:10.3390/cancers13112682
  • Shrestha R, Mohankumar K, Martin G, Hailemariam A, Lee S-O, Jin U-H, Burghardt R, Safe S. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth. J Exp Clin Cancer Res. 2021;40(1):392. doi:10.1186/s13046-021-02199-9
  • Zhang W, Wu Z, Qi H, Chen L, Wang T, Mao X, Shi H, Chen H, Zhong M, Shi X, et al. Celastrol upregulated ATG7 triggers autophagy via targeting Nur77 in colorectal cancer. Phytomedicine. 2022;104:154280. doi:10.1016/j.phymed.2022.154280
  • Yang H, Nie Y, Li Y, Wan YJ. ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells. Biochem Pharmacol. 2011;81(7):910–916. doi:10.1016/j.bcp.2011.01.005
  • Chen Q-T, Zhang Z-Y, Huang Q-L, Chen H-Z, Hong W-B, Lin T, Zhao W-X, Wang X-M, Ju C-Y, Wu L-Z, et al. HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma. Nat Metab. 2022;4(10):1306–1321. doi:10.1038/s42255-022-00642-5
  • Li B, Yao J, Guo K, He F, Chen K, Lin Z, Liu S, Huang J, Wu Q, Fang M, et al. Design, synthesis, and biological evaluation of 5-((8-methoxy-2-methylquinolin-4-yl)amino)-1H-indole-2-carbohydrazide derivatives as novel Nur77 modulators. Eur J Med Chem. 2020;204:112608. doi:10.1016/j.ejmech.2020.112608
  • Li B, Huang J, Liu J, He F, Wen F, Yang C, Wang W, Wu T, Zhao T, Yao J, et al. Discovery of a Nur77-mediated cytoplasmic vacuolation and paraptosis inducer (4-PQBH) for the treatment of hepatocellular carcinoma. Bioorg Chem. 2022;121:105651. doi:10.1016/j.bioorg.2022.105651
  • Halgren T. New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des. 2007;69(2):146–148. doi:10.1111/j.1747-0285.2007.00483.x
  • Halgren TA. Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model. 2009;49(2):377–389. doi:10.1021/ci800324m
  • Fusani L, Palmer DS, Somers DO, Wall ID. Exploring ligand stability in protein crystal structures using binding pose metadynamics. J Chem Inf Model. 2020;60(3):1528–1539. doi:10.1021/acs.jcim.9b00843
  • Clark AJ, Tiwary P, Borrelli K, Feng S, Miller EB, Abel R, Friesner RA, Berne BJ. Prediction of protein-ligand binding poses via a combination of induced fit docking and metadynamics simulations. J Chem Theory Comput. 2016;12(6):2990–2998. doi:10.1021/acs.jctc.6b00201
  • Auerbach SD, Johnson KA. Alternating site ATPase pathway of rat conventional kinesin. J Biol Chem. 2005;280(44):37048–37060. doi:10.1074/jbc.M502984200
  • Chen X, Cao X, Tu X, Alitongbieke G, Xia Z, Li X, Chen Z, Yin M, Xu D, Guo S, et al. BI1071, a Novel Nur77 modulator, induces apoptosis of cancer cells by activating the Nur77-Bcl-2 apoptotic pathway. Mol Cancer Ther. 2019;18(5):886–899. doi:10.1158/1535-7163.MCT-18-0918
  • Hu M, Luo Q, Alitongbieke G, Chong S, Xu C, Xie L, Chen X, Zhang D, Zhou Y, Wang Z, et al. Celastrol-induced Nur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy. Mol Cell. 2017;66(1):141–153 e146. doi:10.1016/j.molcel.2017.03.008
  • Pawlak A, Strzadala L, Kalas W. Non-genomic effects of the NR4A1/Nur77/TR3/NGFIB orphan nuclear receptor. Steroids. 2015;95:1–6. doi:10.1016/j.steroids.2014.12.020
  • Hazel TG, Misra R, Davis IJ, Greenberg ME, Lau LF. Nur77 is differentially modified in Pc12 cells upon membrane depolarization and growth-factor treatment. Mol Cell Biol . 1991;11(6):3239–3246.
  • Kolluri SK, Bruey-Sedano N, Cao X, Lin B, Lin F, Han Y-H, Dawson MI, Zhang X-k. Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol. 2003;23(23):8651–8667. doi:10.1128/MCB.23.23.8651-8667.2003
  • Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat Immunol. 2011;12(8):778–785. doi:10.1038/ni.2063
  • Lin B, Kolluri SK, Lin F, Liu W, Han Y-H, Cao X, Dawson MI, Reed JC, Zhang X-k. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell. 2004;116(4):527–540. doi:10.1016/s0092-8674(04)00162-x
  • Hedrick E, Mohankumar K, Safe S. TGFbeta-induced lung cancer cell migration is NR4A1-dependent. Mol Cancer Res. 2018;16(12):1991–2002. doi:10.1158/1541-7786.MCR-18-0366
  • Li B, Zhu F, He F, Huang Q, Liu X, Wu T, Zhao T, Qiu Y, Wu Z, Xue Y, et al. Synthesis and biological evaluations of N′-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents. Bioorg Chem. 2020;96:103592. doi:10.1016/j.bioorg.2020.103592
  • Zhan Y-y, Chen Y, Zhang Q, Zhuang J-j, Tian M, Chen H-z, Zhang L-r, Zhang H-k, He J-p, Wang W-j, et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat Chem Biol. 2012;8(11):897–904. doi:10.1038/nchembio.1069
  • Wang W-j, Wang Y, Hou P-p, Li F-w, Zhou B, Chen H-z, Bian X-l, Cai Q-x, Xing Y-z, He J-p, et al. Induction of autophagic death in cancer cells by agonizing TR3 and attenuating Akt2 activity. Chem Biol. 2015;22(8):1040–1051. doi:10.1016/j.chembiol.2015.06.023
  • Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221–234. doi:10.1007/s10822-013-9644-8
  • Jacobson MP, Friesner RA, Xiang Z, Honig B. On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol. 2002;320(3):597–608. doi:10.1016/s0022-2836(02)00470-9
  • Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA. A hierarchical approach to all-atom protein loop prediction. Proteins. 2004;55(2):351–367. doi:10.1002/prot.10613
  • Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput. 2021;17(7):4291–4300. doi:10.1021/acs.jctc.1c00302
  • Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70–82. doi:10.1002/pro.3943
  • Desmond. Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2021. New York, NY: Maestro-Desmond Interoperability Tools, Schrödinger; 2021.
  • Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. SC '06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing; 2006, p. 43–43.
  • Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996;14(1):33–38. doi:10.1016/0263-7855(96)00018-5
  • Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25. doi:10.1016/j.softx.2015.06.001
  • Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718. doi:10.1002/jcc.20291
  • DuIvyTools: a tool to process the result files of GMX MD. [accessed 2022 July 17]. https://github.com/CharlesHahn/DuIvyTools.